PharmaVoice Logo

Healthcare Leaders Hub

MCADDI 2026 brings together drug discovery experts at University of Hyderabad

Express Pharma

MCADDI 2026 brings together drug discovery experts at University of Hyderabad

The six-day programme, organised by FABA with academic and industry partners, covers medicinal chemistry, AI-based drug design, biologics and emerging therapeutic modalities The post MCADDI 2026 brings together drug discovery experts at University of Hyderabad appeared first on Express Pharma.

Read Full Article
SCHOTT Poonawalla renamed SCHOTT Pharma India Private Limited

Express Pharma

SCHOTT Poonawalla renamed SCHOTT Pharma India Private Limited

The name change takes effect on October 28, 2026, with no changes to ownership, management, operations, products or services The post SCHOTT Poonawalla renamed SCHOTT Pharma India Private Limited appeared first on Express Pharma.

Read Full Article
Indoco Remedies’ AnaCipher gets ANVISA approval for clinical and bioanalytical facilities

Express Pharma

Indoco Remedies’ AnaCipher gets ANVISA approval for clinical and bioanalytical facilities

The approval authorises the CRO to conduct bioavailability and bioequivalence studies for submission to Brazil, with associated bioanalytical support The post Indoco Remedies’ AnaCipher gets ANVISA approval for clinical and bioanalytical facilities appeared first on Express Pharma.

Read Full Article
ESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial

Pharma Tech

ESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial

Reduced-frequency checkpoint inhibitor treatment could not demonstrate non-inferior PFS and showed a signal of worse survival.

Read Full Article
ESMO26: Intismeran sets new benchmark in adjuvant melanoma

Pharma Tech

ESMO26: Intismeran sets new benchmark in adjuvant melanoma

One notable finding from the INTerpath-001 trial, for which data was presented at ESMO 2026, was when the benefit appeared.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Oct 28, 2026, 7:11 AM

FDA warns Amgen over cancer drug promotional video

In a warning letter dated August 12, the FDA said the video promoted the drug Vectibix as an option for adults with a type of advanced colorectal cancer and noted that infusions can take 60 minutes or less and do not require premedication

ET Pharma

Oct 28, 2026, 7:09 AM

Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit

Jonsson joined Lilly in 1990 as a sales representative in Sweden and went on to hold leadership positions across Europe, Japan and the United States

ET Pharma

Oct 28, 2026, 7:06 AM

Artiva to discontinue cell therapy after two patient deaths, cut workforce by 94%

Artiva's therapy AlloNK was being tested as a potential treatment for autoimmune conditions such as rheumatoid arthritis in a mid-stage trial

PharmaShots

Oct 28, 2026, 6:23 AM

Astellas and Audax Biosciences Sign ~$1.34B Exclusive Option and License Agreement for DAX-044

Shots: Astellas & Audax Biosciences have entered into an exclusive option & license agreement, granting Astellas an option for a worldwide license to develop, manufacture & commercialize DAX-044; Audax retains an option to co-fund & co-promote it in Australia & New Zealand Audax will receive upfront & option exercise payments totaling $285M, up to $1.05B… The post Astellas and Audax Biosciences Sign ~$1.34B Exclusive Option and License Agreement for DAX-044 appeared first on PharmaShots.

Express Pharma

Oct 28, 2026, 6:11 AM

MCADDI 2026 brings together drug discovery experts at University of Hyderabad

The six-day programme, organised by FABA with academic and industry partners, covers medicinal chemistry, AI-based drug design, biologics and emerging therapeutic modalities The post MCADDI 2026 brings together drug discovery experts at University of Hyderabad appeared first on Express Pharma.

Express Pharma

Oct 28, 2026, 6:00 AM

SCHOTT Poonawalla renamed SCHOTT Pharma India Private Limited

The name change takes effect on October 28, 2026, with no changes to ownership, management, operations, products or services The post SCHOTT Poonawalla renamed SCHOTT Pharma India Private Limited appeared first on Express Pharma.

News

Latest industry coverage

Google News

Oct 28, 2026, 8:08 AM

India emerging as center of scientific innovation, commercial growth - Medical Buyer

India emerging as center of scientific innovation, commercial growth  Medical Buyer

Google News

Oct 28, 2026, 8:00 AM

4 Questions pharma leaders can’t skip before letting AI act - pharmaphorum

4 Questions pharma leaders can’t skip before letting AI act  pharmaphorum

Google News

Oct 28, 2026, 7:48 AM

Hengrui Pharma Presents 64 Studies at ESMO 2026, Record for Chinese Oncology Company - The Clinical Trial Vanguard

Hengrui Pharma Presents 64 Studies at ESMO 2026, Record for Chinese Oncology Company  The Clinical Trial Vanguard

Google News

Oct 28, 2026, 7:18 AM

Eli Lilly surges up diabetes reputation rankings to close in on Novo - Fierce Pharma

Eli Lilly surges up diabetes reputation rankings to close in on Novo  Fierce Pharma

Google News

Oct 28, 2026, 7:15 AM

Treasury to Limit Chinese Biotech Deals, But Still Allow Licensing - WSJ

Treasury to Limit Chinese Biotech Deals, But Still Allow Licensing  WSJ

Google News

Oct 28, 2026, 7:11 AM

FDA warns Amgen over cancer drug promotional video - pharma.economictimes.indiatimes.com

FDA warns Amgen over cancer drug promotional video  pharma.economictimes.indiatimes.com

Google News

Oct 28, 2026, 7:09 AM

Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit - pharma.economictimes.indiatimes.com

Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit  pharma.economictimes.indiatimes.com

Google News

Oct 28, 2026, 7:07 AM

Bharat Biotech arm Nucelion inks manufacturing pact with Pandorum to develop ophthalmology therapies - Fortune India

Bharat Biotech arm Nucelion inks manufacturing pact with Pandorum to develop ophthalmology therapies  Fortune India

Google News

Oct 28, 2026, 7:06 AM

Artiva to discontinue cell therapy after two patient deaths, cut workforce by 94% - pharma.economictimes.indiatimes.com

Artiva to discontinue cell therapy after two patient deaths, cut workforce by 94%  pharma.economictimes.indiatimes.com

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer